As of January 22, 2025, Pliant Therapeutics (PLRX) has a market cap of $0.66 billion USD. According to our data, Pliant Therapeutics is ranked No.5761 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.66 B |
-17.08%
|
Dec 31, 2024 | $0.80 B |
-27.28%
|
Dec 29, 2023 | $1.10 B |
-6.31%
|
Dec 30, 2022 | $1.18 B |
43.19%
|
Dec 31, 2021 | $0.82 B |
-40.58%
|
Dec 31, 2020 | $1.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
FibroGen
FGEN
|
$50.79 M |
0.000 M
|
USA
|
Galapagos NV
GLPG
|
$1.58 B |
0.000 M
|
Belgium
|
Genfit
GNFT
|
$0.18 B |
-0.000 M
|
France
|
Morphic Therapeutic
MORF
|
$2.86 B |
0.000 M
|
USA
|
Akero Therapeutics
AKRO
|
$1.75 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Market Cap | = | PLRX Stock Price | * | PLRX Shares Outstanding |
= | $10.92 | * | 60.85 M | |
= | $0.66 B |